Showing results (141-150 of 172) with videos related to

Sort By:
Pageof 18
Journal of Investigational Allergology & Clinical Immunology|March 3, 2021
Spanish Society of Allergology and Clinical Immunology (SEAIC) Vision of Drug Provocation TestsM T Audicana, N Ortega, T Lobera, et al.
Stroke|September 28, 2019
Leveraging Human Genetics to Estimate Clinical Risk Reductions Achievable by Inhibiting Factor XIBenjamin Georgi, Johanna Mielke, Mark Chaffin, et al.
Frontiers in Cellular Neuroscience|February 9, 2017
Deep Sequencing of the Human Retinae Reveals the Expression of Odorant ReceptorsNikolina Jovancevic, Kirsten A Wunderlich, Claudia Haering, et al.
Frontiers in Immunology|March 8, 2021
Immune-Mediated Mechanisms in Cofactor-Dependent Food Allergy and Anaphylaxis: Effect of Cofactors in Basophils and Mast CellsRosa Muñoz-Cano, Clara San Bartolome, Rocío Casas-Saucedo, et al.
Journal of Investigational Allergology & Clinical Immunology|May 4, 2021
Risk Factors in Severe Anaphylaxis: Which Matters the Most, Food or Cofactors?R Casas-Saucedo, C de la Cruz, G Araujo-Sánchez, et al.
The Lancet. Oncology|July 18, 2014
Survival for haematological malignancies in Europe between 1997 and 2008 by region and age: results of EUROCARE-5, a population-based studyMilena Sant, Pamela Minicozzi, Morgane Mounier, et al.
Scientific Reports|September 8, 2019
Closing the Nuclear Fuel Cycle with a Simplified Minor Actinide Lanthanide Separation Process (ALSEP) and Additive ManufacturingArtem V Gelis, Peter Kozak, Andrew T Breshears, et al.
Journal of Neuroengineering and Rehabilitation|December 14, 2023
Body-weight support gait training in neurological intensive care: safety, feasibility, and delays before walking with or without suspensionClaire Jourdan, Fanny Pradalier, Kevin Chalard, et al.
Scientific Reports|January 15, 2020
Author Correction: Closing the Nuclear Fuel Cycle with a Simplified Minor Actinide Lanthanide Separation Process (ALSEP) and Additive ManufacturingArtem V Gelis, Peter Kozak, Andrew T Breshears, et al.
BMJ Open|June 22, 2026
Home-based exoskeleton use to improve quality of life in patients with multiple sclerosis: study protocol of a multicentre, randomised, cross-over trialEmilie Leblong, Maxime Billot, Donze Cecile, et al.
Pageof 18